Next earnings date: 6 Aug 2025

Applied DNA Sciences, Inc. – NASDAQ:APDN
Applied DNA Sciences stock price today
Applied DNA Sciences stock price monthly change
Applied DNA Sciences stock price quarterly change
Applied DNA Sciences stock price yearly change
Applied DNA Sciences key metrics
Market Cap | 9.30M |
Enterprise value | N/A |
P/E | -1.86 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 0.71 |
Price/Book | 1.49 |
PEG ratio | -0.03 |
EPS | -14.30 |
Revenue | 9.03M |
EBITDA | -15.63M |
Income | -10.57M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -38.93% |
Oper. margin | -54.79% |
Gross margin | 32.82% |
EBIT margin | -54.79% |
EBITDA margin | -173.05% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeApplied DNA Sciences stock price history
Applied DNA Sciences stock forecast
Applied DNA Sciences financial statements
Mar 2023 | 4.40M | 588.34K | 13.35% |
---|---|---|---|
Jun 2023 | 2.91M | -3.09M | -106.25% |
Sep 2023 | 779.73K | -3.59M | -460.7% |
Mar 2024 | 929.63K | -4.47M | -480.89% |
Sep 2023 | 779.73K | -3.59M | -460.7% |
---|---|---|---|
Mar 2024 | 929.63K | -4.47M | -480.89% |
Sep 2025 | 2.2M | -24.61M | -1118.74% |
Oct 2025 | 1.8M | -148.12K | -8.23% |
Analysts Price target
Financials & Ratios estimates
2024-08-08 | -0.35 | 0.47 |
---|
Payout ratio | 0% |
---|
2020 | |
---|---|
2021 | |
2022 | 1.09% |
2023 | |
2024 | 9.05% |
Mar 2023 | 19175477 | 9.20M | 48.02% |
---|---|---|---|
Jun 2023 | 15789534 | 8.59M | 54.44% |
Sep 2023 | 13651577 | 8.77M | 64.31% |
Mar 2024 | 9175627 | 9.35M | 101.91% |
Mar 2023 | 214.38K | -54.33K | 0 |
---|---|---|---|
Jun 2023 | -1.36M | -161.8K | 0 |
Sep 2023 | -2.67M | -924.66K | 0 |
Mar 2024 | -3.20M | -14.82K | 3.01M |
Applied DNA Sciences alternative data
Aug 2023 | 61 |
---|---|
Sep 2023 | 61 |
Oct 2023 | 61 |
Nov 2023 | 61 |
Dec 2023 | 61 |
Jan 2024 | 52 |
Feb 2024 | 52 |
Mar 2024 | 52 |
Apr 2024 | 52 |
May 2024 | 52 |
Jun 2024 | 52 |
Jul 2024 | 52 |
Applied DNA Sciences other data
Period | Buy | Sel |
---|---|---|
Jun 2020 | 745000 | 0 |
Mar 2021 | 0 | 13049 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | ANCHIN SCOTT L director | Common Stock | 13,049 | $8.48 | $110,603 | ||
Option | ANCHIN SCOTT L director | Stock Option (right to buy) | 20,834 | $4.26 | $88,753 | ||
Option | ANCHIN SCOTT L director | Common Stock | 13,049 | $2.22 | $28,904 | ||
Purchase | MONTGOMERY WILLIAM W other: ex 5% owner | Applied DNA Sciences Inc. Common Stock | 190,000 | N/A | N/A | ||
Purchase | MONTGOMERY WILLIAM W other: ex 5% owner | Applied DNA Sciences Inc. 5 year warrant | 110,000 | $5.25 | $577,500 | ||
Purchase | MONTGOMERY WILLIAM W other: ex 5% owner | Applied DNA Sciences Inc. Common Stock | 80,000 | N/A | N/A | ||
Purchase | MONTGOMERY WILLIAM W other: ex 5% owner | Applied DNA Sciences Inc. Common Stock | 40,000 | N/A | N/A | ||
Purchase | MONTGOMERY WILLIAM W other: ex 5% owner | Applied DNA Sciences Inc. 5 year warrant | 40,000 | $5.25 | $210,000 | ||
Purchase | MONTGOMERY WILLIAM W other: ex 5% owner | Applied DNA Sciences Inc. Common Stock | 115,000 | N/A | N/A | ||
Purchase | MONTGOMERY WILLIAM W other: ex 5% owner | Applied DNA Sciences Inc. 5 year warrant | 75,000 | $5.25 | $393,750 |
Patent |
---|
Application Filling date: 19 Mar 2021 Issue date: 23 Sep 2021 |
Application Filling date: 17 Dec 2019 Issue date: 25 Jun 2020 |
Quarter | Transcript |
---|---|
Q1 2024 9 Feb 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 8 Dec 2023 | Q4 2023 Earnings Call Transcript |
Q3 2023 12 Aug 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 11 May 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Dr. James A. Hayward Ph.D., Sc.D. (1954) Chairman, Pres & Chief Executive Officer | $391,620 |
Mr. Scott L. Anchin (1974) Strategic Advisor & Independent Director | $325,000 |
Ms. Judith Murrah (1958) Chief Operating Officer & Sec. | $278,270 |
Ms. Beth M. Jantzen CPA, CPA (1976) Chief Financial Officer | $278,270 |
-
What's the price of Applied DNA Sciences stock today?
One share of Applied DNA Sciences stock can currently be purchased for approximately $3.58.
-
When is Applied DNA Sciences's next earnings date?
Applied DNA Sciences, Inc. is estimated to report earnings on Wednesday, 6 Aug 2025.
-
Does Applied DNA Sciences pay dividends?
No, Applied DNA Sciences does not pay dividends.
-
How much money does Applied DNA Sciences make?
Applied DNA Sciences has a market capitalization of 9.30M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 74.33% to 3.43M US dollars. Applied DNA Sciences made a loss 7.23M US dollars in net income (profit) last year or $0.47 on an earnings per share basis.
-
What is Applied DNA Sciences's stock symbol?
Applied DNA Sciences, Inc. is traded on the NASDAQ under the ticker symbol "APDN".
-
What is Applied DNA Sciences's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Applied DNA Sciences?
Shares of Applied DNA Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Applied DNA Sciences's key executives?
Applied DNA Sciences's management team includes the following people:
- Dr. James A. Hayward Ph.D., Sc.D. Chairman, Pres & Chief Executive Officer(age: 71, pay: $391,620)
- Mr. Scott L. Anchin Strategic Advisor & Independent Director(age: 51, pay: $325,000)
- Ms. Judith Murrah Chief Operating Officer & Sec.(age: 67, pay: $278,270)
- Ms. Beth M. Jantzen CPA, CPA Chief Financial Officer(age: 49, pay: $278,270)
-
How many employees does Applied DNA Sciences have?
As Jul 2024, Applied DNA Sciences employs 52 workers.
-
When Applied DNA Sciences went public?
Applied DNA Sciences, Inc. is publicly traded company for more then 22 years since IPO on 15 Jul 2003.
-
What is Applied DNA Sciences's official website?
The official website for Applied DNA Sciences is adnas.com.
-
Where are Applied DNA Sciences's headquarters?
Applied DNA Sciences is headquartered at 50 Health Sciences Drive, Stony Brook, NY.
-
How can i contact Applied DNA Sciences?
Applied DNA Sciences's mailing address is 50 Health Sciences Drive, Stony Brook, NY and company can be reached via phone at +63 18408800.
Applied DNA Sciences company profile:

Applied DNA Sciences, Inc.
adnas.comNASDAQ
52
Medical - Diagnostics & Research
Healthcare
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Stony Brook, NY 11790
CIK: 0000744452
ISIN: US03815U3005
CUSIP: 03815U300